Clinical Trials Directory

Trials / Terminated

TerminatedNCT04280354

Molecular Biomarkers for Sepsis

Prospective Study to Discover New Biomarkers for Early Detection of Sepsis and Prediction of Sepsis-related Mortality in Patients With Severe Community Acquired Pneumonia (sCAP)

Status
Terminated
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This multi-center observational case-control study in Intensive Care Unit (ICU) patients is to identify novel biomarkers allowing to recognize severe community acquired pneumonia (sCAP) -associated sepsis at an earlier stage and predict sepsis-related mortality. Patients with sCAP (cases) will be profoundly characterized over time regarding the development of sepsis and compared with control patients. The mechanisms and influencing factors on the clinical course will be explored with most modern -omics technologies allowing a detailed characterisation. These data will be analysed using machine learning algorithms and multi-dimensional mathematical models.

Conditions

Interventions

TypeNameDescription
OTHERcompare data patterns by data-driven algorithms to determine sepsiscompare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to reliably determine sepsis
OTHERcompare data patterns by data-driven algorithms to predict sepsis-related mortalitycompare data patterns by data-driven algorithms including machine learning and multi-dimensional modelling to to predict sepsis-related mortality

Timeline

Start date
2022-02-16
Primary completion
2022-07-31
Completion
2022-07-31
First posted
2020-02-21
Last updated
2024-05-09

Locations

15 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04280354. Inclusion in this directory is not an endorsement.